Metabolomic analysis of the aqueous humor from patients with central retinal vein occlusion using UHPLC-MS/MS.


Journal

Journal of pharmaceutical and biomedical analysis
ISSN: 1873-264X
Titre abrégé: J Pharm Biomed Anal
Pays: England
ID NLM: 8309336

Informations de publication

Date de publication:
05 Sep 2020
Historique:
received: 15 04 2020
revised: 21 06 2020
accepted: 23 06 2020
pubmed: 6 7 2020
medline: 22 6 2021
entrez: 5 7 2020
Statut: ppublish

Résumé

Central retinal vein occlusion (CRVO) is one of the retinal fundus diseases and may result in irreversible visual impairment. Metabolic dysfunction has been proved to play an essential role in the pathogenesis of CRVO. We performed untargeted metabolomic analysis of the aqueous humor (AH) of patients with CRVO and controls using UHPLC-MS/MS. A total of 248 metabolites were identified in the tested AH samples, 37 of which allowed for the construction of an orthogonal partial least squares discriminant analysis model with good predictive capability (Q2cum = 0.834) and low risk of overfitting. The components contributing the most to the metabolomic signature of CRVO were those related to amino acid metabolism, carbohydrates, and fatty acid metabolites (variable importance on projection>1.0 and p < 0.05). The CRVO group appeared to have a lower AH concentration of carbohydrates and amino acids, but a relative higher concentration of carnitine-associated energetic substrates (butyryl carnitine, deoxycarnitine, N6-trimethyl-l-lysine) and osmolytes compared with those of the control group. These results indicate that patients with CRVO may have ocular aberrations in metabolic pathways involving certain amino acids, fatty acids, and carbohydrates. These metabolite changes might correlate with energy dysfunction and inflammation response in the AH of CRVO patients. This finding may provide insight into the pathophysiology of CRVO for the development of new therapeutic strategies.

Identifiants

pubmed: 32622112
pii: S0731-7085(20)31334-0
doi: 10.1016/j.jpba.2020.113448
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

113448

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None of the authors has a financial or proprietary interest in any material or method mentioned.

Auteurs

Pinghui Wei (P)

Tianjin Eye Hospital, Tianjin Key Lab of Ophthalmology and Visual Science, Nankai University, Tianjin, PR China; Clinical College of Ophthalmology, Tianjin Medical University, Tianjin, PR China.

Meiqin He (M)

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, PR China.

He Teng (H)

Eye Institute and School of Optometry and Ophthalmology, Tianjin Medical University Eye Hospital, Tianjin, PR China.

Guoge Han (G)

Tianjin Eye Hospital, Tianjin Key Lab of Ophthalmology and Visual Science, Nankai University, Tianjin, PR China; Clinical College of Ophthalmology, Tianjin Medical University, Tianjin, PR China. Electronic address: dovehanguoge@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH